Big studies give long-awaited answers on who does and does not benefit from these popular nutrients. Fish oil taken by healthy people, at a dose found in many supplements, showed no clear ability to lower heart or cancer risks. Same for vitamin D.
All news from Marine Medicine
Researchers who checked patients' blood samples for medication concentration found that more than half were taking prescription and/or over-the-counter drugs not listed in their electronic health record (EHR), indicating potential threats to patient safety.
In proof-of-concept experiments, researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. The researchers deliver this therapeutic enzyme via the cellular equivalent of a Trojan Horse, using tiny blood cell platelets as their protective delivery vehicle, with a key enzyme hidden inside.
Scientists are pursuing a cross-collaborative effort that could potentially change the way cellular immunotherapies such as stem cell transplantation and CAR T-cell therapies are performed. In the Cellular Immunotherapy and Transplantation Program at Virginia Commonwealth University Massey Cancer Center, scientists are pursuing a cross-collaborative effort that could potentially change the way cellular immunotherapies such as stem cell transplantation and CAR T-cell therapies are performed.
A cancer therapy based on fusing two types of cells into a single unit shows promise in strengthening existing treatments for acute myeloid leukemia. The approach joins blood platelets that carry cancer drugs with stem cells that guide the platelets into bone marrow where leukemia begins.
Physicians who believe they have been subjected to unfair treatment and/or discipline by a state medical board, physician health program (PHP), or other regulatory bodies now have a place to turn for information, advice, and support.
In its first year, an innovative virtual program has substantially increased mistreated elderly Texans' access to elder mistreatment and geriatric experts with The University of Texas Health Science Center at Houston (UTHealth).
The fat in a donor liver and the fat in the recipient increase risk for death after transplant, according to results from a new study. This does not mean that obese patients should be denied liver transplants, or that high-macrosteatosis livers should be thrown away, said Patrick Northup, MD, from the University of Virginia School of Medicine in Charlottesville.
"It will be harder to feed 9 billion people in 2050 than it would be today," said Gibran Vita, a Ph.D. candidate at the Norwegian University of Science and Technology 's Industrial Ecology Program.
A drug therapy used for patients with chronic heart failure also improves markers of poor prognosis in individuals who are hospitalized with acute heart failure, new Yale-led research shows. The findings suggest that the drug can improve outcomes for acutely ill heart patients and potentially become the new standard of care for treating this serious condition, the researchers said.